NEVVI Medicare utilization intelligence

← back

WADE, TAYLORFNP-C NPI 1689139040 Clinician

Nurse Practitioner · JACKSONVILLE, AL

Specialty Nurse Practitioner — from billed Medicare claims
Trained UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE — medical school, self-reported to CMS
In practice about 8 years since medical school (class of 2018, self-reported to CMS)
Location JACKSONVILLE, AL · NPPES registered location
Active in data Billed Medicare 2020–2024 (5 consecutive years)
Scale 28 codes billed · 3,831 disclosed volume (CY2024 — most recent year in data)
Current groups

Group affiliation since 2019

20202026
DOCTORS MED CARE OF JACKSONVILLE, P.C.
2020–2026

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2021-01

Year: 2024 · 2023 · 2022  · 2021  · 2020 

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were in CY2024. Included with Platform.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Volume Beneficiary-episodes Avg charge Avg Medicare payment
J0696 Injection, ceftriaxone sodium, per 250 mg
96372 Injection of drug or substance under skin or into muscle
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg
J1100 Injection, dexamethasone sodium phosphate, 1 mg
87804 Detection test by immunoassay with direct visual observation for influenza virus
87811 Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19)
71046 X-ray of chest, 2 views
87430 Detection test by immunoassay technique for streptococcus, group a (strep)
J1885 Injection, ketorolac tromethamine, per 15 mg
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
81002 Urinalysis, manual test
82962 Blood glucose (sugar) test performed by hand-held instrument
70210 X-ray of paranasal sinus, 1-2 views
36415 Insertion of needle into vein for collection of blood sample
70220 X-ray of paranasal sinus, minimum of 3 views
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
94640 Inhalation treatment for airway obstruction or sputum production
94664 Evaluation of use of breathing device
86308 Screening test for mononucleosis (mono)
J1580 Injection, garamycin, gentamicin, up to 80 mg
83036 Hemoglobin a1c level
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
J0736 Injection, clindamycin phosphate, 300 mg
J2010 Injection, lincomycin hcl, up to 300 mg
72100 X-ray of lower and sacral spine, 2-3 views
86677 Analysis for antibody to helicobacter pylori (gastrointestinal bacteria)

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.